SCHEMBL162396

SCHEMBL162396

CCc1cnc(C)c(C)n1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 2/20 0.35
NOS2 P35228 2/20 0.35
PDE10A Q9Y233 1/20 0.35
NOS1 P29475 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29693595 1.00 NOS3 (0.35) NOS3NOS2PDE10ANOS1
SCHEMBL28052944 0.91 PDE10A (0.32) NOS3NOS2PDE10A
SCHEMBL28744976 0.84
SCHEMBL9953811 0.81 NOS3 (0.39) NOS3NOS2PDE10ANOS1
SCHEMBL29419867 0.81 MAPKAPK2 (0.34) NOS3NOS2
SCHEMBL293166 0.81 MAPKAPK2 (0.34) NOS3NOS2
SCHEMBL3838990 0.81 NOS3 (0.33) NOS3NOS2
SCHEMBL1426102 0.81 NOS3 (0.33) NOS3NOS2
SCHEMBL11233578 0.79 NOS3 (0.32) NOS3NOS2
SCHEMBL21534323 0.79 NOS3 (0.41) NOS3NOS2NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 354 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260096585-A1 ORAL COMPOSITION KAO CORPORATION (JP) 2026-04-09 US claimed
EP-4518663-B1 RODENT CONTROL BY ALTERNATE OLFACTORY SIMULATION MELCHIOR MATERIAL & LIFE SCIENCE FRANCE (FR) 2025-12-17 EP claimed
EP-4591720-A1 ORAL COMPOSITION Kao Corporation (JP) 2025-07-30 EP claimed
US-20250212908-A1 CHOCOLATE CONSUMABLES PRODUCED FROM CACAO WASTE PRODUCTS Voyage Foods, Inc. 2025-07-03 US claimed
CN-120041253-A Incense base for increasing aroma characteristics of nuts of cigarettes and preparation method and application thereof 江苏中烟工业有限责任公司 2025-05-27 CN claimed
CN-119947594-A Oral composition 花王株式会社 2025-05-06 CN claimed
CN-119931891-A Pediococcus acidilactici capable of producing various pyrazines and application thereof 北京工商大学 2025-05-06 CN claimed
CN-119896286-A Yeast culture for ruminant feeding and preparation method and application thereof 安琪酵母股份有限公司 2025-04-29 CN claimed
CN-119901556-A Qu Xiang reference sample of medium-temperature Daqu as well as preparation method and application thereof 泸州品创科技有限公司 2025-04-29 CN claimed
CN-119842550-A Pediococcus pentosaceus capable of producing various pyrazines and application thereof 北京工商大学 2025-04-18 CN claimed
US-8158180-B2 Process for the preparation of a flavoring concentrate SYMRISE GMBH & CO. KG (DE) 2012-04-17 US claimed
EP-2385098-A1 Method for manufacturing an aroma concentrate and aroma concentrate Symrise AG (DE) 2011-11-09 EP claimed
EP-2075321-B1 Method for manufacturing an aroma concentrate and aroma concentrate SYMRISE AG (DE) 2011-08-03 EP claimed
US-20100233330-A1 BAKED COMPOSITION NESTEC S.A. (CH) 2010-09-16 US claimed
EP-2164335-A2 BAKED COMPOSITION NESTEC S.A. (CH) 2010-03-24 EP claimed
EP-2075321-A1 Method for manufacturing an aroma concentrate and aroma concentrate Symrise GmbH & Co. KG (DE) 2009-07-01 EP claimed
EP-2075320-A1 Method for manufacturing an aroma concentrate and aroma concentrate Symrise GmbH & Co. KG (DE) 2009-07-01 EP claimed
US-20090155446-A1 PROCESS FOR THE PREPARATION OF A FLAVORING CONCENTRATE, AND A FLAVORING CONCENTRATE SYMRISE GMBH & CO. KG (DE) 2009-06-18 US claimed
WO-2008148737-A2 BAKED COMPOSITION NESTEC S.A. (CH) 2008-12-11 WO claimed
EP-2000032-A1 Baked composition Nestec S.A. (CH) 2008-12-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260096585-A1 ORAL COMPOSITION TAS2R5, TAS2R16, TAS2R45 NOS3 3580/4885NOS2 4111/4885PDE10A 985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.